Deka Bank Deutsche Girozentrale Corcept Therapeutics Inc Transaction History
Deka Bank Deutsche Girozentrale
- $54.1 Billion
- Q4 2024
A detailed history of Deka Bank Deutsche Girozentrale transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 7,360 shares of CORT stock, worth $535,219. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,360
Previous 7,360
-0.0%
Holding current value
$535,219
Previous $319,000
21.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
392Shares Held
86.5MCall Options Held
1.13MPut Options Held
749K-
Black Rock Inc. New York, NY16.5MShares$1.2 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$736 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$589 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$451 Million0.49% of portfolio
-
Parallel Advisors, LLC3.83MShares$278 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.79B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...